Max Robotics — Global Service Robot Directory + US Certification

About

Siamak Daneshmand is a leading urologic oncologist whose research has fundamentally advanced the surgical management of bladder and prostate cancers, particularly through the adoption and refinement of robotic techniques. His most impactful work centers on replicating open surgical principles in minimally invasive settings, most notably with the robotic intracorporeal orthotopic ileal neobladder—a procedure detailed in his highly cited 2012 paper (183 citations). Daneshmand has not only demonstrated the technical feasibility of this complex reconstruction but has also rigorously evaluated its functional outcomes, including urodynamics and health-related quality of life (89 citations). His contributions extend to optimizing oncologic outcomes, as seen in his systematic review on the effectiveness of extended pelvic lymphadenectomy for prostate cancer survival (37 citations) and a large multicenter analysis comparing surgical approaches for upper tract urothelial carcinoma (30 citations). Beyond direct patient care, Daneshmand is a pioneer in surgical education, having developed and validated several objective assessment tools—such as the End-to-End Assessment of Suturing Expertise (EASE) and the Cystectomy Assessment and Surgical Evaluation (CASE)—that provide targeted feedback to robotic trainees. His innovative use of machine learning to analyze surgeon performance metrics and predict positive surgical margins further underscores his commitment to data-driven improvement. With over 400 citations across his top works, Daneshmand’s research seamlessly blends technical innovation, rigorous outcome analysis, and a dedication to training the next generation of robotic surgeons.